Tagged with Investment

Switzerland Italian-speaking Swiss canton Ticino outperforms most regions within Europe, yet still lags behind the high-flying cantons of Northern Switzerland. Stefano Rizzi, director of the canton’s economic division, discusses its economic development strategy and the important role that the life sciences sector plays within it. Ticino is the Italian-speaking region of…

Greece Vassilios Katsos, President & CEO of Pharmathen, articulates the philosophy that has led to the company’s strong market positioning: innovation, internationalization and investment. Based on this triumvirate of strategies, he describes Pharmathen’s ability to keep pace with the global market while maintaining a focus on R&D and operational excellence. As one…

Switzerland With a population of only 350,000, Ticino has a remarkably well developed pharmaceutical cluster. FIT Chairman Giorgio Calderari explains that the cluster’s key strength lies in the diverse range of capabilities which its members are able to offer as contract services to one another, and of course other interested third…

Greece General Manager of the Hellenic Association of Pharmaceutical Companies (SFEE), Mihalis Himonas speaks about his role spearheading Greece’s main pharma association, the contribution of the pharma industry to GDP, market access challenges, and solutions for creating a sustainable healthcare environment. As the organization representing the united voice of the pharmaceutical…

Philippines Basic Philippines country facts The Philippines is among the world’s fastest growing economies. The Philippines’ economic performance for 2016 was steady, with GDP up almost a whole percentage point on 2015. Most of the Philippines’ wealth is centred in the capital Manila, with other, more rural areas, significantly poorer. The…

Ireland Aidan Meagher, Tax Partner & Irish Life Sciences Lead for EY Ireland, discusses EY’s extensive consulting work, including their efforts to promote entrepreneurship in Ireland, the changing landscape facing the medtech industry in the country as well as how Ireland can work to make itself an even more attractive destination…

Switzerland As the largest privately owned pharmaceutical company in Switzerland, IBSA remains committed to continuing to invest and manufacture in Switzerland. Head of Swiss Business Operations Maleša Ulrico Sidjanski, MSc ETH, discusses the company’s current priorities, values, and upcoming investments.   What other mid-sized multinational pharmaceutical companies present in over 80…

Taiwan Chih-Kung Lee, Minister of Economic Affairs of the Republic of China (Taiwan) provides insights into Taiwan’s “new economic model” recently established by the new government to boost the country’s economic growth and ensure Taiwan renews its role as an innovation pioneer. He also documents the crucial role that the pharmaceutical…

Philippines Javish Abichandani, Chief Executive Officer of AGlobal Care Inc. in the Philippines, outlines the company’s extensive product portfolio as well as their ambitions to bring more high-quality, affordable medications into the Philippines. He also discusses how the company is evolving to meet the demands of the dynamic pharmaceutical industry in…

Slovakia Deloitte Slovakia’s Chairman, Vladimir Masar, talks about the transferability of his financial banking experience to the consultancy sector, the country’s attractiveness to foreign investment and the current state of its healthcare system. Given your extensive experience of the public and private sectors, could you tell our global executive readers about…

Switzerland Bernhard Neidhart, head of Office for Economy and Labor in Zug, introduces us to the Canton of Zug and explains how the region became a hotspot for pharma.   To begin Dr. Neidhart, could you please introduce us to the Canton of Zug? How does Zug’s “value proposition” compare to…

Switzerland For the eighth year in a row the World Economic Forum has ranked Switzerland first in both global competitiveness and in innovation; economiesuisse CEO Monika Rühl discusses the main issues which threaten this leading position, and the overall growth prospects for the Swiss economy. To begin, could you please introduce…